Floatz logo

Hydrochlorothiazide

Abdominal Obesity

UMC UtrechtSmall moleculePhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Abdominal Obesity cohort.

Asset / SponsorPhaseRating
Moxonidine
Baker Heart and Diabetes Institute
Phase 4BB
Elafibranor
Genfit
Phase 2BB
UMBELLATINE
China National Center for Cardiovascular Diseases
Phase 4BB
Irbesartan
Baker Heart and Diabetes Institute
Phase 4BB
CARVEDILOL
St. Paul Heart Clinic
Phase 3B

View all 27 →

Same molecule, other indications

Hydrochlorothiazide is also rated in:

essential hypertensionDormant
BBB
Indicative ·
77 / 100
View asset →
hypertensive disorderDormant
BBB
Indicative ·
77 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →